Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrenkel Topping Regulatory News (FEN)

Share Price Information for Frenkel Topping (FEN)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £61.45m
FEN Live PriceLast checked at - London Stock Exchange

Intraday Frenkel Topping Share Chart

Trading Statement

20 Jan 2014 15:33

RNS Number : 0890Y
Frenkel Topping Group PLC
20 January 2014
 



 

 

Press Release

20 January 2014

 

Frenkel Topping Group plc

 

("Frenkel Topping", "the Company" or, together with its subsidiaries "the Group")

 

Trading Update

 

Frenkel Topping (AIM:FEN), the provider of specialist independent financial advice on the investment of personal injury damages and clinical negligence awards, today releases a trading update ahead of the release of its final results announcement for the year ended 31 December 2013, which is expected towards the end of March 2014.

 

The Company announces that due to an excellent year of new business, its final results for the year ended 31 December 2013 are expected to be ahead of market expectations.

 

During the year the Group exceeded £0.5 billion of Funds in the Investment Management Service. In addition, its best of breed investment solutions have been embedded and well received in the market place, which is expected to result in an increase in gross, operating and net profit margins.

 

David Southworth, Chairman of Frenkel Topping commented: "The Board is pleased to confirm that the Company's results for the full year are expected to be ahead of market expectations. The Group made considerable progress during the year, having successfully prepared for the legal reforms and considerable changes to benefits entitlement which occurred in 2013, as well as growing the Funds in the Investment Management Service to over £0.5 billion."

 

- Ends -

 

For further information please contact:

Frenkel Topping Group Plc

Richard Fraser, Chief Executive

Tel: +44 (0)161 886 8000

Shore Capital

Pascal Keane / Patrick Castle

Tel:+44 (0)20 7408 4090

 

Media enquiries:

Abchurch

Joanne Shears / Jamie Hooper

Tel: +44 (0) 20 7398 7719

Jamie.hooper@abchurch-group.com

www.abchurch-group.com

 

Notes to Editors:

 

About Frenkel Topping

Frenkel Topping Limited ("Frenkel Topping") is the trading subsidiary of Frenkel Topping Group Plc.

 

Frenkel Topping provides specialist independent financial advice on the investment of personal injury damages and clinical negligence awards. Frenkel Topping offers a complete service for all personal injury claims handlers, lawyers and individual clients, dealing with awards from tens of thousand pounds to multi-million pound cases. Frenkel Topping's expertise includes asset protection, bespoke investment portfolios, analysis of periodical payments, Court of Protection portfolios and provision and setting up of trustee and receivership bank accounts. Frenkel Topping has over £0.5 billion of clients' funds in its investment management service.

 

The Group's strategy is to continue to grow its Funds in Investment Management Services organically and to maintain steady levels of recurring revenues at their current high levels of circa. 70%. The Group's strong market position means that it is well poised for future growth.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBUGDBIDDBGSG
Date   Source Headline
29th Jan 202011:40 amRNSForm 8.3 - FRENKEL TOPPING GROUP PLC
28th Jan 20202:35 pmRNSForm 8 (DD) - Frenkel Topping Group plc
28th Jan 20209:04 amRNSStatement re Possible Offer
9th Dec 20197:00 amRNSTrading Statement
3rd Sep 20197:00 amRNSHalf-year Report
27th Aug 20197:00 amRNSNotice of Results
23rd Aug 201911:56 amRNSHolding(s) in Company
15th Jul 20192:14 pmRNSFrenkel Topping comment re: Ogden rate
3rd Jun 20197:00 amRNSAppointment of Tatton Asset Management to Ascencia
30th May 201912:35 pmRNSResult of AGM
30th May 20197:00 amRNSAGM Statement
9th May 20197:00 amRNSFrenkel Topping Deputy Day
10th Apr 20197:00 amRNSFinal Results
5th Mar 20196:04 pmRNSTransaction in own shares and TVR
1st Feb 20194:12 pmRNSTransaction in Own Shares
31st Jan 20197:00 amRNSPre Close Trading Update
13th Dec 20187:00 amRNSTransaction in own shares and TVR
4th Dec 20189:27 amRNSTransaction in Own Shares and TVR
22nd Nov 20184:47 pmRNSDirector/PDMR Shareholding
22nd Nov 20187:00 amRNSShare Buy Back Programme
14th Nov 201810:19 amRNSDirector/PDMR Shareholding
13th Nov 20187:00 amRNSTrading Update
5th Sep 20187:00 amRNSInterim Results
27th Jul 20182:27 pmRNSHolding(s) in Company
11th Jul 20187:00 amRNSBusiness and trading update
19th Jun 20188:00 amRNSAppointment of Joint Broker
19th Jun 20187:00 amRNSBoard Changes
11th Apr 20182:00 pmRNSDirector/PDMR Shareholding
9th Apr 20188:25 amRNSFinal Results
20th Mar 20187:00 amRNSNotice of Results
7th Feb 20187:00 amRNSAppointment of Portfolio Research Partner
20th Dec 20177:00 amRNSStrategic Update
18th Dec 20177:00 amRNSTransaction in Own Shares
15th Dec 20177:00 amRNSShare Buyback, Director Dealing & Resignation
1st Dec 20177:00 amRNSEmployee Benefit Trust Purchase
14th Nov 20177:00 amRNSTrading Update
2nd Oct 20177:00 amRNSDirectorate Appointment and Board Change
28th Sep 201711:00 amRNSHolding(s) in Company
22nd Sep 20172:16 pmRNSHolding(s) in Company
21st Sep 20171:11 pmRNSHolding(s) in Company
20th Sep 20175:21 pmRNSHolding(s) in Company
20th Sep 20174:46 pmRNSHolding(s) in Company
20th Sep 20174:44 pmRNSHolding(s) in Company
20th Sep 20174:42 pmRNSHolding(s) in Company
18th Sep 20179:26 amRNSPCA Dealing & Concert Party Update
6th Sep 20177:00 amRNSDirector/PDMR Shareholding
7th Aug 20177:00 amRNSDirectorate Change
1st Aug 20178:45 amRNSDirector Dealing
18th Jul 201710:17 amRNSDirector/PDMR Shareholding
13th Jul 20178:19 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.